Truist Financial’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-45,395
Closed -$430K 2625
2025
Q1
$430K Sell
45,395
-4,979
-10% -$50.3K ﹤0.01% 1951
2024
Q4
$567K Sell
50,374
-21,520
-30% -$378K ﹤0.01% 1801
2024
Q3
$2.03M Sell
71,894
-7,374
-9% -$190K ﹤0.01% 1221
2024
Q2
$1.52M Sell
79,268
-3,733
-4% -$95.3K ﹤0.01% 1405
2024
Q1
$2.72M Sell
83,001
-2,225
-3% -$71K ﹤0.01% 1141
2023
Q4
$2.82M Sell
85,226
-463
-0.5% -$13.1K ﹤0.01% 1092
2023
Q3
$2.33M Sell
85,689
-2,355
-3% -$65.5K ﹤0.01% 1163
2023
Q2
$2.67M Sell
88,044
-4,805
-5% -$155K ﹤0.01% 1123
2023
Q1
$3.01M Sell
92,849
-16,884
-15% -$534K 0.01% 1039
2022
Q4
$3.08M Sell
109,733
-1,709
-2% -$49K 0.01% 1015
2022
Q3
$4M Buy
111,442
+1,796
+2% +$63.3K 0.01% 863
2022
Q2
$3.37M Sell
109,646
-332
-0.3% -$9.67K 0.01% 960
2022
Q1
$3.55M Buy
+109,978
New +$2.88M 0.01% 1021
2020
Q3
Sell
-2,220
Closed -$15K 2467
2020
Q2
$15K Buy
+2,220
New +$14.9K ﹤0.01% 2372

Other funds holding EVH

Truist Financial's EVH Position: Q2 2025 in Review

Truist Financial sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 45,395 shares — an estimated $430K sold.

Truist Financial first reported a position in EVH in Q2 2020 and held it in 14 quarters. The position peaked at $4M in Q3 2022. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Truist Financial reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Truist Financial sold 45,395 Evolent Health shares in Q2 2025, an estimated $430K.
  • Truist Financial first reported a position in Evolent Health in Q2 2020 and held it in 14 quarters.
  • Truist Financial's Evolent Health position peaked at $4M in Q3 2022.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Truist Financial's 13F filing for Q2 2025, filed 18 Jul 2025.